Clinical Trial

Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the efficacy and safety of the Beach regimen on relapsed/refractory acute myeloid leukemia
Trial Details
NCT Number NCT07651475
Lead Sponsor Liping Dou
Conditions R/R AML
Enrollment 32 participants
Start Date 2026-03-31
Primary Completion 2026-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-16